Home > Insider Trading > Filing (0001415889-23-014659)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1325618	Iradimed Corp	IRMD	Surgical & Medical Instruments & Apparatus (3841)	731408526

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1613801	E. Roger Susi	C/O Iradimed Corporation 1025 Willa Springs Dr. Winter Springs FL 32708	Ceo, President, Chairman	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2023-10-30	5,000	$39.92	247,950	No	4	S	Indirect	By Roger E. Susi Revocable Trust
Common Stock	Disposition	2023-10-31	5,000	$40.40	242,950	No	4	S	Indirect	By Roger E. Susi Revocable Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Roger E. Susi Revocable Trust
No	4	S	Indirect	By Roger E. Susi Revocable Trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	2,362,500	Indirect	By Matthew Susi 2008 Dynasty Trust
Common Stock	2,362,500	Indirect	By Phillip Susi 2008 Dynasty Trust

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 13, 2023.
This transaction was executed in multiple trades at prices ranging from $38.99 to $40.37. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $39.81 to $40.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose.